Marina Biotech, Inc.

Common Stock SEC Reporting - Current

OTC Disclosure & News Service

Release Date Title Type
Nov 20, 2014 Marina Biotech Reports That Partner Mirna Therapeutics Presented Interim Phase 1 Data on Its First-in-Class microRNA-34 Mimic Press Release
Nov 18, 2014 Rosetta Genomics and Marina Biotech Initiate First Clinical Project Under Strategic Alliance Press Release
Nov 17, 2014 Marina Biotech Announces Third Quarter 2014 Financial Results Press Release
Sep 17, 2014 OTC Markets Group Welcomes Marina Biotech to OTCQB Announcement
Sep 16, 2014 Marina Biotech Announces the Election of Donald A. Williams to Its Board of Directors Press Release
Sep 11, 2014 Marina Biotech Announces the Continued Worldwide Expansion of Its Delivery Technology Intellectual Property Estate Press Release
Dec 06, 2012 Marina Biotech, Inc. Announces Year-to-Date 2012 Financial Results and Highlights Corporate Accomplishments Press Release
Dec 05, 2012 Marina Biotech Announces that Licensee ProNAi Therapeutics Reported Phase 1 Study Results using SMARTICLES® Nucleic Acid Delivery Technology Press Release
Dec 04, 2012 Marina Biotech Receives Key Patent Issuance from the USPTO for its Unlocked Nucleobase Analog (UNA) Chemistry - Patent broadly covers RNA-based oligonucleotide therapeutics containing a UNA Press Release
Nov 29, 2012 Marina Biotech Announces Worldwide Non-Exclusive Licensing Agreement Press Release
Oct 11, 2012 Marina Biotech, Inc. Announces Full Year 2011 Financial Results Press Release
Aug 22, 2012 Marina Biotech Provides Update on Company Operations Press Release
Aug 03, 2012 Marina Biotech Announces Worldwide Non-Exclusive Licensing Agreement for Nucleic Acid Chemistry Press Release
Jun 01, 2012 Marina Biotech Ceases Most Day-to-Day Operations Press Release
May 21, 2012 Marina Biotech and Girindus Group Announce Strategic Alliance Press Release
May 10, 2012 Marina Biotech Receives Three Notices of Allowances from the USPTO and an Intent to Grant Notice from the European Patent Office Press Release
May 08, 2012 Marina Biotech Announces Worldwide Exclusive Licensing Agreement with Monsanto Press Release
Apr 19, 2012 Marina Biotech Regains Intellectual Property Rights to its tkRNAi™ Technology for Agriculture and Veterinary Uses Press Release
Apr 03, 2012 Marina Biotech Completes Dosing of Second Cohort in the Phase 1b START-FAP Clinical Trial of CEQ508 Press Release
Mar 19, 2012 Marina Biotech, Inc. to Raise $1.2 Million in Registered Direct Offering Press Release